Conditions: Non-myeloid Malignancies Chemotherapy Induced Anaemia
Keywords: cancer chemotherapy induced anaemia iron Patients with non-myeloid malignancies and Chemotherapy Induced Anaemia (CIA) CIA
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 350
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare the efficacy and safety of intravenous iron therapy with oral iron therapy in patients with cancer and chemotherapy induced anaemia.

Detailed description:

Arms:
arm 1: Iron isomaltoside intravenously as bolus or infusion arm 2: oral iron sulphate twice a day

Interventions: intervention 1: iron isomaltoside 1000 intervention 2: iron sulphate
Intervention descriptions: intervention 1: intravenously as bolus or infusion, 500 mg or 1000mg up to full replacement dose intervention 2: oral, 200 mg per day (100 mg bid),12 weeks

Protocol document: